Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-17-049
Prinicipal Investigator
Brown, Valerie
Phase
Phase I/II
Age Group
Both
Scope
National
Secondary Protocol No.
POE16-01
Title
A Phase I/II Study of Neratinib in Pediatric Patients with Relapsed or Refractory Solid Tumors or Hematologic Malignancies
Objective
Primary Objective:
Ph I Component: To establish DLT & MTD, and RP2D of neratinib in r/r pediatric malignancies
Ph II Component: To assess the efficacy of neratinib in r/r pediatric malignancies at the RP2D
Applicable Disease Sites
Any Site
Status
Open
Participating Institutions
Hershey Medical Center